Exemestane

Learn about Exemestane, an aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. Discover its uses, dosage, an

Exemestane Exemestane breast cancer Exemestane mechanism of action Exemestane side effects Exemestane dosage Aromatase inhibitor Exemestane Exemestane postmenopausal breast cancer Hormone therapy breast cancer
🏷 ATC Code: L02BG06 📂 Antineoplastic and immunomodulating agents / Endocrine therapy / Hormone antagonists and related agents / Aromatase inhibitors 🕐 Updated: Mar 13, 2026 ✓ Medical Reference

Looking to order Exemestane?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Exemestane?

Exemestane is an oral medication primarily used in the treatment of breast cancer. It belongs to a class of drugs known as aromatase inhibitors. Specifically, Exemestane is a selective, irreversible steroidal aromatase inactivator, meaning it permanently blocks the enzyme aromatase. This enzyme is crucial for the production of estrogen in the body, particularly in postmenopausal women. By reducing estrogen levels, Exemestane helps to slow or stop the growth of certain types of breast cancer that are sensitive to hormones.

This medication is typically prescribed for women who have gone through menopause and have hormone receptor-positive breast cancer, which relies on estrogen to grow. Its development marked a significant advancement in endocrine therapy for cancer, offering a targeted approach to disrupt cancer cell proliferation.

How Does it Work?

The primary mechanism of action for Exemestane revolves around its ability to inhibit the aromatase enzyme. In postmenopausal women, the ovaries no longer produce significant amounts of estrogen. Instead, the main source of estrogen is the conversion of androgens (male hormones) into estrogen by the aromatase enzyme, which is found in various tissues, including fat, muscle, and breast tissue. Cancer cells in hormone receptor-positive breast cancer often have receptors that bind to estrogen, stimulating their growth.

Exemestane acts as a 'suicide inhibitor' of aromatase. It structurally resembles the natural substrates of the enzyme, allowing it to bind to the active site of aromatase. Once bound, it forms a permanent, covalent bond with the enzyme, irreversibly inactivating it. This process significantly reduces the amount of circulating estrogen in the body, depriving estrogen-sensitive breast cancer cells of the hormone they need to grow and multiply. This reduction in estrogen levels helps to shrink existing tumors and prevent new ones from forming.

Medical Uses

Exemestane is approved for specific indications in the management of breast cancer:

  • Adjuvant Treatment of Early Breast Cancer: It is used in postmenopausal women with hormone receptor-positive, early invasive breast cancer who have completed 2 to 3 years of initial adjuvant tamoxifen therapy and are then switched to Exemestane for the completion of a total of 5 years of adjuvant endocrine therapy. This sequential therapy aims to further reduce the risk of cancer recurrence.
  • Treatment of Advanced Breast Cancer: Exemestane is also indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following therapy with anti-estrogen treatments like tamoxifen. In this setting, it provides an alternative hormonal therapy option when first-line treatments are no longer effective.

While its primary use is in breast cancer, Exemestane has occasionally been used off-label for other conditions where estrogen suppression is beneficial, such as in men with gynecomastia (enlarged breasts) or to manage estrogen levels in certain athletic contexts, though these uses are not FDA-approved and should be discussed thoroughly with a healthcare professional.

Dosage

The standard recommended dosage for Exemestane in the treatment of breast cancer is 25 mg taken orally once daily. It is crucial to take the tablet after a meal, as food can significantly increase the absorption of the medication, ensuring optimal efficacy. Consistency in timing, such as taking it at the same time each day, is also important.

The duration of treatment with Exemestane varies depending on the specific medical condition and the patient's response. For early breast cancer, it is typically part of a multi-year endocrine therapy regimen, often following or switching from tamoxifen. For advanced breast cancer, treatment continues as long as the patient benefits from the therapy and tolerates the medication. Patients should never adjust their dosage or discontinue the medication without consulting their prescribing physician.

Side Effects

Like all medications, Exemestane can cause side effects. These are generally related to the reduction in estrogen levels in the body. Common side effects include:

  • Hot flashes
  • Fatigue or weakness
  • Joint pain (arthralgia) and muscle pain
  • Headache
  • Nausea
  • Increased sweating
  • Insomnia or trouble sleeping
  • Hair thinning
  • Bone density loss (osteoporosis), which can increase the risk of fractures. Regular bone density monitoring is often recommended.

Less common but potentially serious side effects can include elevated liver enzymes, cardiovascular events (e.g., increased cholesterol levels), and allergic reactions. Patients should report any persistent, severe, or unusual symptoms to their doctor immediately. It's important to discuss the potential benefits and risks with a healthcare provider before starting treatment.

Drug Interactions

Several drug interactions can affect the efficacy or safety of Exemestane. It is metabolized primarily by the cytochrome P450 3A4 (CYP3A4) enzyme system. Therefore, medications that significantly induce this enzyme can reduce Exemestane levels in the blood, potentially decreasing its effectiveness. Examples of strong CYP3A4 inducers include:

  • Rifampicin (an antibiotic)
  • Phenytoin (an anti-epileptic drug)
  • Carbamazepine (an anti-epileptic and mood-stabilizing drug)
  • St. John's wort (a herbal supplement)

Conversely, strong CYP3A4 inhibitors might increase Exemestane levels, though this interaction is generally less clinically significant. It is also critical to avoid co-administration with estrogen-containing medications, such as hormone replacement therapy (HRT) or oral contraceptives. These medications would counteract the estrogen-lowering effects of Exemestane, rendering it ineffective for breast cancer treatment. Always inform your doctor and pharmacist about all prescription, over-the-counter, and herbal supplements you are taking to prevent potential interactions.

FAQ

Q: Is Exemestane a form of chemotherapy?

A: No, Exemestane is not chemotherapy. It is a type of hormone therapy (specifically, an aromatase inhibitor) that works by reducing estrogen levels in the body, which helps to treat hormone receptor-positive breast cancer.

Q: Can men take Exemestane?

A: While primarily used in postmenopausal women for breast cancer, Exemestane is sometimes prescribed off-label for men in specific situations, such as managing gynecomastia or certain conditions requiring estrogen suppression. This should always be under strict medical supervision.

Q: How long do I need to take Exemestane?

A: The duration of Exemestane treatment varies. For early breast cancer, it's often part of a 5-year endocrine therapy plan, sometimes after initial tamoxifen. For advanced breast cancer, treatment may continue as long as it is effective and well-tolerated.

Q: What should I do if I miss a dose?

A: If you miss a dose of Exemestane, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

Q: Does Exemestane cause weight gain?

A: Weight gain can be a possible side effect of Exemestane, though not everyone experiences it. Changes in metabolism due to estrogen reduction can contribute to this. Maintaining a healthy diet and regular exercise can help manage this side effect.

Products containing Exemestane are available through trusted online pharmacies. You can browse Exemestane-based medications at ShipperVIP or Medicenter.

Summary

Exemestane is a vital medication in the therapeutic arsenal against hormone receptor-positive breast cancer in postmenopausal women. As a potent, irreversible aromatase inhibitor, it effectively reduces estrogen levels, thereby curbing the growth of estrogen-dependent tumors. It is used both in the adjuvant setting for early breast cancer and for advanced disease that has progressed after other anti-estrogen therapies. While generally well-tolerated, awareness of its potential side effects, particularly bone loss and common menopausal-like symptoms, is crucial. Furthermore, understanding its drug interactions is essential for safe and effective treatment. Patients considering or undergoing Exemestane therapy should maintain close communication with their healthcare providers to optimize outcomes and manage any adverse effects.